申请人:Adams Jerry Leroy
公开号:US20100317663A1
公开(公告)日:2010-12-16
The present invention relates to a compound of formula (I):
or a pharmaceutically acceptable salt thereof, wherein R
1
-R
4
, Q, Z, r, and p are as defined herein. Compounds of the present invention are useful in the treatment of diseases associated with FAK overexpression, including proliferative diseases.
本发明涉及式(I)的化合物:
或其药学上可接受的盐,其中R1-R4,Q,Z,r和p如本文中所定义。本发明的化合物在治疗与FAK过度表达相关的疾病中是有用的,包括增殖性疾病。